Form 4 for BCDA BioCardia, Inc.
Accepted 2023-05-22 00:00:00 ET · period of report 2023-05-18 · accession 0001437749-23-015516 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-22 | 2023-05-18 | BCDA | McClung David | CFO | A - Grant | $1.70 | +61.4K | 152.1K | +68% | +$104.4K |
| D | 2023-05-22 | 2023-05-18 | BCDA | McClung David | CFO | A - Grant | $0.00 | +68.3K | 68.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-18 | A | A | 61,389 | $1.70 | 152,120 | D | — | — | (F1) The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on May 18, 2023. |
| 2 | Derivative | Stock Option (right to buy) | 2023-05-18 | A | A | 68,265 | $0.00 | 68,265 | D | $1.70 · — to 2033-05-18 | 68,265 Common Stock | (F2) The option vests and becomes exercisable as to 1/48th of the shares on June 18, 2023, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. |